New 5-in-1 meningitis shot for babies tested in africa
NCT ID NCT05093829
Summary
This study tested a new vaccine designed to protect infants against five major strains of deadly bacterial meningitis (A, C, W, Y, and X). Over 1,300 healthy infants in Mali received either the new vaccine or an existing one at either 9 or 15 months of age, alongside their routine shots. The main goal was to see if the new vaccine was as safe and effective at triggering protective immunity as the current vaccine, and if it interfered with other routine infant vaccinations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre pour le Developpement des Vaccins du Mali
Bamako, Mali
Conditions
Explore the condition pages connected to this study.